369 related articles for article (PubMed ID: 23399889)
21. Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy.
Sturm E; Fellner L; Krismer F; Poewe W; Wenning GK; Stefanova N
Neurotherapeutics; 2016 Oct; 13(4):871-879. PubMed ID: 27259295
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity.
Kuzdas-Wood D; Fellner L; Premstaller M; Borm C; Bloem B; Kirik D; Wenning GK; Stefanova N
BMC Neurosci; 2015 Dec; 16():86. PubMed ID: 26627686
[TBL] [Abstract][Full Text] [Related]
23. Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.
Kisos H; Pukaß K; Ben-Hur T; Richter-Landsberg C; Sharon R
PLoS One; 2012; 7(10):e46817. PubMed ID: 23077527
[TBL] [Abstract][Full Text] [Related]
24. A Mouse Model of Multiple System Atrophy: Bench to Bedside.
Stefanova N
Neurotherapeutics; 2023 Jan; 20(1):117-126. PubMed ID: 35995919
[TBL] [Abstract][Full Text] [Related]
25. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
Marmion DJ; Rutkowski AA; Chatterjee D; Hiller BM; Werner MH; Bezard E; Kirik D; McCown T; Gray SJ; Kordower JH
Neurobiol Dis; 2021 Jan; 148():105184. PubMed ID: 33221532
[TBL] [Abstract][Full Text] [Related]
26. A mouse model of adult-onset multiple system atrophy.
Tanji K; Miki Y; Mori F; Nikaido Y; Narita H; Kakita A; Takahashi H; Wakabayashi K
Neurobiol Dis; 2019 Jul; 127():339-349. PubMed ID: 30910745
[TBL] [Abstract][Full Text] [Related]
27. Neuropathology of multiple system atrophy: new thoughts about pathogenesis.
Jellinger KA
Mov Disord; 2014 Dec; 29(14):1720-41. PubMed ID: 25297524
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic insights into multiple system atrophy from a PLP-α-synuclein transgenic mouse model.
Nicholson L; Piras IS; DeBoth MD; Siniard A; Heras-Garvin A; Stefanova N; Huentelman MJ
Brain Res; 2024 Jul; 1834():148912. PubMed ID: 38575106
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.
Stefanova N; Reindl M; Neumann M; Haass C; Poewe W; Kahle PJ; Wenning GK
Am J Pathol; 2005 Mar; 166(3):869-76. PubMed ID: 15743798
[TBL] [Abstract][Full Text] [Related]
30. [Mechanism of neuronal degeneration of multiple system atrophy].
Yoshida M; Sone M
Brain Nerve; 2009 Sep; 61(9):1051-60. PubMed ID: 19803404
[TBL] [Abstract][Full Text] [Related]
31. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
[TBL] [Abstract][Full Text] [Related]
32. SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy.
Kon T; Forrest SL; Lee S; Li J; Chasiotis H; Nassir N; Uddin MJ; Lang AE; Kovacs GG
Neurobiol Dis; 2024 Aug; 198():106551. PubMed ID: 38839023
[TBL] [Abstract][Full Text] [Related]
33. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy.
Koga S; Dickson DW
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):175-184. PubMed ID: 28860330
[TBL] [Abstract][Full Text] [Related]
35. Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications.
Schafferer S; Khurana R; Refolo V; Venezia S; Sturm E; Piatti P; Hechenberger C; Hackl H; Kessler R; Willi M; Gstir R; Krogsdam A; Lusser A; Poewe W; Wenning GK; Hüttenhofer A; Stefanova N
PLoS One; 2016; 11(3):e0150705. PubMed ID: 26962858
[TBL] [Abstract][Full Text] [Related]
36. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the Retina of Plp-α-Syn Mice as a Model for Studying Synuclein-Dependent Diseases.
Kaehler K; Seitter H; Sandbichler AM; Tschugg B; Obermair GJ; Stefanova N; Koschak A
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):12. PubMed ID: 32503050
[TBL] [Abstract][Full Text] [Related]
38. FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models.
Vidal-Martinez G; Segura-Ulate I; Yang B; Diaz-Pacheco V; Barragan JA; De-Leon Esquivel J; Chaparro SA; Vargas-Medrano J; Perez RG
Exp Neurol; 2020 Mar; 325():113120. PubMed ID: 31751571
[TBL] [Abstract][Full Text] [Related]
39. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
[TBL] [Abstract][Full Text] [Related]
40. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.
Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ
J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
